Oroxylin A attenuated CS-induced lung histopathologic changes, expression of cytokines TNF-α, IL-1β, and MCP-1.
Oroxylin A inhibited the levels of oxidative biomarkers 3-nitrotyrosine and 8-isoprostane.
Oroxylin A up-regulated GSH level and glutathione reductase (GR) activity in lung tissues.
In vitro, oroxylin A significantly up-regulated Nrf2 expression and total cellular glutathione level in CSE-stimulated cells.
In addition, oroxylin A promoted heme oxygenase-1, GPx, and GR expression in CSE-stimulated cells.